Mario Mikula

9PUBLICATIONS
20CO-AUTHORS
Molecular targetsPredictive and prognostic markersMedical biochemistry - lipidsMedical bacteriology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Dec 22, 2025
mTORC2 inhibition reduces tumor burden via STAT1 activation and enhanced response to anti-PD-L1 therapy.

Anna Gschwendtner, Birgit Schütz, Madalina A Mirea

|Jun 20, 2024
Late stage melanoma is hallmarked by low NLGN4X expression leading to HIF1A accumulation.

David Schörghofer, Laurenz Vock, Madalina A Mirea

|Dec 24, 2021
Proteome analysis of NRF2 inhibition in melanoma reveals CD44 up-regulation and increased apoptosis resistance upon vemurafenib treatment.

Hans Peter Weitzenböck, Anna Gschwendtner, Christoph Wiesner

|Nov 27, 2021
Plasma Membrane Lipids: An Important Binding Site for All Lipoprotein Classes.

Markus Axmann, Birgit Plochberger, Mario Mikula

|Dec 16, 2020
STAT3 promotes melanoma metastasis by CEBP-induced repression of the MITF pathway.

Alexander Swoboda, Robert Soukup, Oliver Eckel

|Sep 09, 2020
Insights into Differentiation of Melanocytes from Human Stem Cells and Their Relevance for Melanoma Treatment.

Madalina A Mirea, Stefan Eckensperger, Markus Hengstschläger

Pageof 2

Frequent Collaborators

3 joint publications

Herbert Stangl

2 joint publications

Richard Moriggl

1 joint publications

Clemens Röhrl

1 joint publications

Katharina Kinslechner